Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

Autor: Chang-Jiun Wu, Gillian I. Horwitz, Qing Chang, Hongai Xia, Gerald C. Chu, Ramsey Al-Khalil, Qiuyun Wang, Jianhua Zhang, Timothy P. Heffernan, Alison Liewen, Eliot Fletcher-Sananikone, Avnish Kapoor, Piergiorgio Pettazzoni, Alexei Protopopov, Anguraj Sadanandam, Wantong Yao, Carol Lim, Randy L. Johnson, Giulio Draetta, Ronald A. DePinho, Nora S. Sanchez, Y. Alan Wang, Shan Jiang, Haoqiang Ying, Lynda Chin, Yi Zhong, Baoli Hu, Huamin Wang, Andrea Viale, Sujun Hua
Rok vydání: 2014
Předmět:
endocrine system diseases
Cell
Cell Cycle Proteins
medicine.disease_cause
Mice
0302 clinical medicine
media_common
YAP1
0303 health sciences
Cell Cycle
TEA Domain Transcription Factors
Cell cycle
3. Good health
DNA-Binding Proteins
medicine.anatomical_structure
030220 oncology & carcinogenesis
Adenocarcinoma
KRAS
E2F Transcription Factors
Carcinoma
Pancreatic Ductal

DNA Replication
media_common.quotation_subject
Biology
DNA-binding protein
General Biochemistry
Genetics and Molecular Biology

Article
Proto-Oncogene Proteins p21(ras)
03 medical and health sciences
Cell Line
Tumor

Proto-Oncogene Proteins
Pancreatic cancer
medicine
Animals
Humans
Transcription factor
neoplasms
Adaptor Proteins
Signal Transducing

030304 developmental biology
Biochemistry
Genetics and Molecular Biology(all)

Addiction
YAP-Signaling Proteins
Phosphoproteins
medicine.disease
digestive system diseases
Pancreatic Neoplasms
Disease Models
Animal

ras Proteins
Cancer research
Transcription Factors
Zdroj: Cell. 158(1):185-197
ISSN: 0092-8674
DOI: 10.1016/j.cell.2014.06.003
Popis: Activating mutations in KRAS are among the most frequent events in diverse human carcinomas and are particularly prominent in human pancreatic ductal adenocarcinoma (PDAC). An inducible Kras(G12D)-driven mouse model of PDAC has established a critical role for sustained Kras(G12D) expression in tumor maintenance, providing a model to determine the potential for and the underlying mechanisms of Kras(G12D)-independent PDAC recurrence. Here, we show that some tumors undergo spontaneous relapse and are devoid of Kras(G12D) expression and downstream canonical MAPK signaling and instead acquire amplification and overexpression of the transcriptional coactivator Yap1. Functional studies established the role of Yap1 and the transcriptional factor Tead2 in driving Kras(G12D)-independent tumor maintenance. The Yap1/Tead2 complex acts cooperatively with E2F transcription factors to activate a cell cycle and DNA replication program. Our studies, along with corroborating evidence from human PDAC models, portend a novel mechanism of escape from oncogenic Kras addiction in PDAC.
Databáze: OpenAIRE